🔥 Thursday 22 May 2025 Thu, 22 May 2025

Rapid Lithium Limited has agreed to acquire two high-grade silver projects in New South Wales, adding nearly 35 million silver equivalent ounces to its portfolio. The deal, valued at A$6.5 million, signals a strategic diversification into critical minerals amid a robust silver market.

Hutchison Telecommunications (Amsterdam) B.V. has announced an off-market takeover bid for the 12.13% of Hutchison Telecommunications (Australia) Limited shares it does not already own, offering a 52.4% premium. The move aims to consolidate full ownership of the Australian telecom operator.

Hawsons Iron Ltd confirms the technical viability of a fully dry processing circuit for its Hawsons Iron Project, promising cost and environmental benefits. An updated prefeasibility study and maiden ore reserves are expected soon.

Atlantic Lithium has announced the discovery of spodumene pegmatite with high-grade lithium assays at its Agboville and Rubino licences in Côte d’Ivoire, marking a significant expansion beyond its flagship Ghana project.

Zelira Therapeutics has published full results from a Phase I study showing its cannabinoid-based therapy ZLT-L-007 significantly outperforms Lyrica® in managing diabetic neuropathy pain and related symptoms.

Lincoln Minerals’ Kookaburra Graphite Project has delivered battery-grade graphite purity exceeding 99.95%, confirming its suitability for lithium-ion battery anodes through a safer, hydrofluoric acid-free process.

Comms Group Ltd launches a $7 million capital raising, including a fully underwritten entitlement offer, to acquire Tasmanian IT services provider TasmaNet, aiming to boost its revenue and market reach significantly.

Argenica Therapeutics has expanded its intellectual property with a new US patent targeting surgically induced strokes, enhancing the commercial potential of its lead drug candidate ARG-007.

DeSoto Resources has expanded gold-in-soil anomalies at its Timbakouna project to 3.7km and identified new zones at Dadjan, while progressing power auger drilling across multiple sites in Guinea’s Siguiri Basin.

GQG Partners reported robust financial results for 2024 with significant growth in funds under management and earnings, underscoring its adaptability and alignment with shareholders. The 2025 Annual Meeting confirmed strong investor confidence with near-unanimous director re-election.

Solstice Minerals has pinpointed promising mineral resource extension targets at its Nanadie Copper-Gold Project in Western Australia, setting the stage for a potential significant increase in copper and gold resources.

Altamin Limited has reported the final tranche of high-grade zinc-lead-silver assay results from its 2024 channel sampling at the Gorno Project, revealing mineralisation beyond current resource boundaries. These findings highlight new zones in previously inaccessible areas, reinforcing the project's exploration potential.

West African Resources reports exceptional high-grade gold intercepts from diamond drilling below existing reserves at its M1 South underground mine, signaling a potential boost to its resource base and long-term production outlook.

Arika Resources has identified 10 significant new gold targets at its Ithaca Prospect near Genesis Minerals’ Ulysses-Orient Well operation, setting the stage for upcoming drill testing at the Kookynie Gold Project.

New Frontier Minerals advances its NWQ Copper Project by securing bulk sample processing at Austral Resources’ Mt Kelly plant, accelerating its path to copper production in Queensland’s Mt Isa Copper Belt.

Australian Agricultural Company Limited (AACo) reported a 14% rise in operating profit to $58.4 million for FY25, driven by increased sales volumes and disciplined cost control despite challenging market conditions. The company also marked a significant reduction in statutory loss, signaling improved financial resilience.

Australian Agricultural Company Limited (AACo) reported a robust FY25 operating profit of $58.4 million, driven by increased meat and cattle sales volumes and strategic brand growth despite inflationary pressures.

Australian Agricultural Company Limited (AACo) has reported a robust turnaround in its FY25 results, with significant gains in revenue and profitability driven by higher sales volumes and improved operational efficiency.

Oceania Healthcare reported a 4.1% rise in underlying EBITDA for FY25, driven by strong sales and operational improvements, while launching a new strategic plan focused on growth and efficiency.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.